Curebase Secures $40 Million in Series B Funding
/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, has raised $40 million in Series B funding to continue development...
Stay updated with breaking news from Tom Lemberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, has raised $40 million in Series B funding to continue development...
The round included a strategic investment from pharma giant Gilead Sciences to expand their partnership for decentralized and hybrid trials.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- The winners of Fast Company's 2022 World Changing Ideas Awards were announced today, honoring clean technology, innovative corporate...
/PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, today announced the initiation of the pilot phase of COMPANION, the...